to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.
Contact:
Tiffany Hamilton
Head of Communications
Tiffany.Hamilton@ocugen.com
(Tables to follow)
OCUGEN, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)
(Unaudited)
September 30, 2024 December 31, 2023
-------------------- -------------------
Assets
Current assets
Cash $ 38,696 $ 39,462
Prepaid expenses and other
current assets 1,977 3,509
--- --------------- --- --------------
Total current assets 40,673 42,971
Property and equipment, net 17,130 17,290
Restricted cash 305 --
Other assets 3,828 4,286
--- --------------- --- --------------
Total assets $ 61,936 $ 64,547
=== =============== === ==============
Liabilities and stockholders'
equity
Current liabilities
Accounts payable $ 1,494 $ 3,172
Accrued expenses and other
current liabilities 12,475 13,343
Operating lease obligations 477 574
Current portion of long term
debt 1,316 --
--- --------------- --- --------------
Total current liabilities 15,762 17,089
Non-current liabilities
Operating lease obligations,
less current portion 3,419 3,567
Long term debt, net 1,571 2,800
Other non-current liabilities 554 527
--- --------------- --- --------------
Total non-current liabilities 5,544 6,894
--- --------------- --- --------------
Total liabilities 21,306 23,983
--- --------------- --- --------------
Total stockholders' equity 40,630 40,564
--- --------------- --- --------------
Total liabilities and
stockholders' equity $ 61,936 $ 64,547
=== =============== === ==============
OCUGEN, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(Unaudited)
Three months ended Nine months ended
September 30, September 30,
-----------------------
2024 2023 2024 2023
Collaborative
arrangement
revenue $ 1,136 $ 3,699 $ 3,291 $ 4,627
Total revenue 1,136 3,699 3,291 4,627
Operating
expenses
Research and
development 8,108 7,048 23,836 31,794
General and
administrative 6,280 9,082 20,372 26,839
------- ------- ------- -------
Total operating
expenses 14,388 16,130 44,208 58,633
------- ------- ------- -------
Loss from
operations (13,252) (12,431) (40,917) (54,006)
Other income
(expense), net 282 714 743 1,898
======= ======= ======= =======
Net loss $(12,970) $(11,717) $(40,174) $(52,108)
======= ======= ======= =======
(END) Dow Jones Newswires
November 08, 2024 06:45 ET (11:45 GMT)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。